Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

191 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correlation of immunohistochemical staining p63 and TTF-1 with EGFR and K-ras mutational spectrum and diagnostic reproducibility in non small cell lung carcinoma.
Thunnissen E, Boers E, Heideman DA, Grünberg K, Kuik DJ, Noorduin A, van Oosterhout M, Pronk D, Seldenrijk C, Sietsma H, Smit EF, van Suylen R, von der Thusen J, Vrugt B, Wiersma A, Witte BI, den Bakker M. Thunnissen E, et al. Virchows Arch. 2012 Dec;461(6):629-38. doi: 10.1007/s00428-012-1324-x. Epub 2012 Oct 12. Virchows Arch. 2012. PMID: 23064619
Implementation of Novel Molecular Biomarkers for Non-small Cell Lung Cancer in the Netherlands: How to Deal With Increasing Complexity.
van den Broek D, Hiltermann TJN, Biesma B, Dinjens WNM, 't Hart NA, Hinrichs JWJ, Leers MPG, Monkhorst K, van Oosterhout M, Scharnhorst V, Schuuring E, Speel EM, van den Heuvel MM, van Schaik RHN, von der Thüsen J, Willems SM, de Visser L, Ligtenberg MJL. van den Broek D, et al. Front Oncol. 2020 Jan 22;9:1521. doi: 10.3389/fonc.2019.01521. eCollection 2019. Front Oncol. 2020. PMID: 32039011 Free PMC article. Review.
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients.
Hurkmans DP, Kuipers ME, Smit J, van Marion R, Mathijssen RHJ, Postmus PE, Hiemstra PS, Aerts JGJV, von der Thüsen JH, van der Burg SH. Hurkmans DP, et al. Among authors: von der thusen jh. Cancer Immunol Immunother. 2020 May;69(5):771-777. doi: 10.1007/s00262-020-02506-x. Epub 2020 Feb 12. Cancer Immunol Immunother. 2020. PMID: 32047958 Free PMC article.
Sensitive detection methods are key to identify secondary EGFR c.2369C>T p.(Thr790Met) in non-small cell lung cancer tissue samples.
Keppens C, Dequeker EMC, Rouleau E, 't Hart N, Bubendorf L, Dufraing K, Garrec C, Guéguen P, Lamy A, Marchetti A, Pauwels P, Ryska A, Tack V, Tornillo L, Van Casteren K, von der Thüsen JH, Zwaenepoel K, Lissenberg-Witte B, Thunnissen E, Schuuring E. Keppens C, et al. Among authors: von der thusen jh. BMC Cancer. 2020 May 1;20(1):366. doi: 10.1186/s12885-020-06831-3. BMC Cancer. 2020. PMID: 32357863 Free PMC article.
Formalin fixation for optimal concordance of programmed death-ligand 1 immunostaining between cytologic and histologic specimens from patients with non-small cell lung cancer.
Koomen BM, van der Starre-Gaal J, Vonk JM, von der Thüsen JH, van der Meij JJC, Monkhorst K, Willems SM, Timens W, 't Hart NA. Koomen BM, et al. Among authors: von der thusen jh. Cancer Cytopathol. 2021 Apr;129(4):304-317. doi: 10.1002/cncy.22383. Epub 2020 Oct 27. Cancer Cytopathol. 2021. PMID: 33108706 Free PMC article.
Development and validation of a supervised deep learning algorithm for automated whole-slide programmed death-ligand 1 tumour proportion score assessment in non-small cell lung cancer.
Hondelink LM, Hüyük M, Postmus PE, Smit VTHBM, Blom S, von der Thüsen JH, Cohen D. Hondelink LM, et al. Among authors: von der thusen jh. Histopathology. 2022 Mar;80(4):635-647. doi: 10.1111/his.14571. Epub 2021 Nov 16. Histopathology. 2022. PMID: 34786761 Free PMC article.
The impact of a pathologist's personality on the interobserver variability and diagnostic accuracy of predictive PD-L1 immunohistochemistry in lung cancer.
Butter R, Hondelink LM, van Elswijk L, Blaauwgeers JLG, Bloemena E, Britstra R, Bulkmans N, van Gulik AL, Monkhorst K, de Rooij MJ, Slavujevic-Letic I, Smit VTHBM, Speel EM, Thunnissen E, von der Thüsen JH, Timens W, van de Vijver MJ, Yick DCY, Zwinderman AH, Cohen D, 't Hart NA, Radonic T. Butter R, et al. Among authors: von der thusen jh. Lung Cancer. 2022 Apr;166:143-149. doi: 10.1016/j.lungcan.2022.03.002. Epub 2022 Mar 5. Lung Cancer. 2022. PMID: 35279453 Free article.
191 results